Effectiveness and Safety of Palbociclib Plus Endocrine Therapy in Patients with Advanced Breast Cancer: A Multi-Center Study in China

SIMPLE SUMMARY: Palbociclib is one of the preferred treatments for hormone-receptor-positive, HER2-negative metastatic breast cancer in women; its effectiveness and safety in the Chinese real-world population require further investigation. Our study aimed to identify the clinical outcomes of patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Xinyu, Jin, Nan, Gao, Hongfei, Yan, Min, Chen, Qianjun, Sun, Tao, Hao, Chunfang, Zhao, Yanxia, Han, Xinhua, Pan, Yueyin, Huang, Xiang, Li, Wei, Wang, Kun, Yin, Yongmei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487219/
https://www.ncbi.nlm.nih.gov/pubmed/37686645
http://dx.doi.org/10.3390/cancers15174360

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487219/
https://www.ncbi.nlm.nih.gov/pubmed/37686645
http://dx.doi.org/10.3390/cancers15174360

Ejemplares similares